Consolidated Statement Of Comprehensive Income

Fuji Pharma Co.,Ltd. - Filing #7339242

Concept 2023-10-01 to
2024-03-31
2022-10-01 to
2023-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
4,257,000,000 JPY
1,772,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,090,000,000 JPY
3,167,000,000 JPY
Deferred gains or losses on hedges
42,000,000 JPY
-15,000,000 JPY
Foreign currency translation adjustment
142,000,000 JPY
196,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-3,000,000 JPY
-1,000,000 JPY
Other comprehensive income
-908,000,000 JPY
3,347,000,000 JPY
Comprehensive income
3,349,000,000 JPY
5,120,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,349,000,000 JPY
5,120,000,000 JPY
Comprehensive income attributable to non-controlling interests
0 JPY
0 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.